In last trading session, NLS Pharmaceutics Ltd (NASDAQ:NLSP) saw 1.03 million shares changing hands with its beta currently measuring -0.83. Company’s recent per share price level of $0.18 trading at $0.01 or 5.94% at ring of the bell on the day assigns it a market valuation of $6.42M. That closing price of NLSP’s stock is at a discount of -788.89% from its 52-week high price of $1.60 and is indicating a premium of 22.22% from its 52-week low price of $0.14. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.62 million shares which gives us an average trading volume of 476.98K if we extend that period to 3-months.
NLS Pharmaceutics Ltd (NASDAQ:NLSP) trade information
Upright in the green during last session for gaining 5.94%, in the last five days NLSP remained trading in the red while hitting it’s week-highest on Wednesday, 03/20/24 when the stock touched $0.18 price level, adding 52.63% to its value on the day. NLS Pharmaceutics Ltd’s shares saw a change of -69.49% in year-to-date performance and have moved -41.75% in past 5-day. NLS Pharmaceutics Ltd (NASDAQ:NLSP) showed a performance of -56.10% in past 30-days. Number of shares sold short was 61820.0 shares which calculate 1.48 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -16.06% during past 5 years.
NLSP Dividends
NLS Pharmaceutics Ltd is more likely to be releasing its next quarterly report in April and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
NLS Pharmaceutics Ltd (NASDAQ:NLSP)’s Major holders
Insiders are in possession of 34.98% of company’s total shares while institution are holding 16.63 percent of that, with stock having share float percentage of 25.57%. Investors also watch the number of corporate investors in a company very closely, which is 16.63% institutions for NLS Pharmaceutics Ltd that are currently holding shares of the company. BVF Inc. is the top institutional holder at NLSP for having 5.75 million shares of worth $6.32 million. And as of Jun 29, 2023, it was holding 17.72% of the company’s outstanding shares.
The second largest institutional holder is Affinity Asset Advisors, Llc, which was holding about 0.4 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 1.23% of outstanding shares, having a total worth of $0.44 million.
